Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Sam Altman, Musk and OpenAI

Digest more
 · 9h
Sam Altman Despises Elon Musk. Now He Is Going After His Companies
Over the last year, the feud between Silicon Valley heavyweights Sam Altman and Elon Musk has devolved into personal attacks, social media swipes, and lawsuits. Musk calls his foe

Continue reading

 · 3d · on MSN
Sam Altman, OpenAI will reportedly back a startup that takes on Musk’s Neuralink
 · 3d
OpenAI, cofounder Sam Altman to take on Neuralink with new startup
1don MSN

Sam Altman’s rival to Neuralink reportedly eying gene therapy technology

A novel gene therapy idea is reportedly among the focus areas considered by Merge Labs, a new brain-computer interface ...
3d

Did Sam Altman Accidentally Admit That The AI Bubble Is Here?

A recent CNBC interview with the OpenAI CEO shows that tech leaders are changing how they judge AI models.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

To meet Trump in Wash.
Trump: No deal reached
'General Hospital' star dies
To remove DC police chief
New Orleans mayor indicted
Erin becomes a Category 5
Man fleeing ICE raid killed
'House of Cards' actor dies
Power banks recalled
Greg Iles dies at 65
Rules out presidential bid
Sean Kingston sentenced
Jeff Bezos' mother dies
Del Records CEO sentenced
Denmark train accident
Flu vaccine at home
Sweden mosque shooting
To visit Mexico in September
Flight attendants strike
Reds place Burns on IL
Ryazan plant fire kills 11
Trump shifts to peace deal
Retail sales rise in July
California man rescued
DOJ sues California
NCAA fines Michigan
Calls second special session
Sickle cell drug fails
US consumer sentiment falls
Buys stake in UnitedHealth
Court: CFPB cuts can resume
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy